Teerasarntipan Tongluk, Thanapirom Kessarin, Chaiteerakij Roongruedee, Komolmit Piyawat, Treeprasertsuk Sombat
Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand.
World J Gastroenterol. 2024 Dec 7;30(45):4781-4790. doi: 10.3748/wjg.v30.i45.4781.
Acute liver failure (ALF) in dengue is rare but fatal. Early identification of patients who are at risk of ALF is the key strategy to improve survival.
To validate prognostic scores for predicting ALF and in-hospital mortality in dengue-induced severe hepatitis (DISH).
We retrospectively reviewed 2532 dengue patients over a period of 16 years (2007-2022). Patients with DISH, defined as transaminases > 10 times the normal reference level and DISH with subsequent ALF, were included. Univariate regression analysis was used to identify factors associated with outcomes. Youden's index in conjunction with receiver operating characteristic (ROC) analysis was used to determine optimal cut-off values for prognostic scores in predicting ALF and in-hospital death. Area under the ROC (AUROC) curve values were compared using paired data nonparametric ROC curve estimation.
Of 193 DISH patients, 20 developed ALF (0.79%), with a mortality rate of 60.0%. International normalized ratio, bilirubin, albumin, and creatinine were independent predictors associated with ALF and death. Prognostic scores showed excellent performance: Model for end-stage liver disease (MELD) score ≥ 15 predicted ALF (AUROC 0.917, sensitivity 90.0%, specificity 88.4%) and ≥ 18 predicted death (AUROC 0.823, sensitivity 86.9%, specificity 89.1%); easy albumin-bilirubin (ALBI) score ≥ -30 predicted ALF and death (ALF: AUROC 0.835, sensitivity80.0%, specificity 72.2%; death: AUROC 0.808, sensitivity 76.9%, specificity 69.3%); ALBI score ≥ -2 predicted ALF and death (ALF: AUROC 0.806, sensitivity 80.0%, specificity 77.4%; death: AUROC 0.799, sensitivity 76.9%, specificity 74.3%). Platelet-ALBI score also showed good performance in predicting ALF and death (AUROC = 0.786 and 0.699, respectively). MELD and EZ-ALBI scores had similar performance in predicting ALF ( = 1.688, = 0.091) and death ( = 0.322, = 0.747).
MELD score is the best predictor of ALF and death in DISH patients. EZ-ALBI score, a simpler yet effective score, shows promise as an alternative prognostic tool in dengue patients.
登革热所致急性肝衰竭(ALF)虽罕见但致命。早期识别有ALF风险的患者是提高生存率的关键策略。
验证用于预测登革热所致严重肝炎(DISH)患者发生ALF及住院死亡率的预后评分。
我们回顾性分析了16年(2007 - 2022年)期间的2532例登革热患者。纳入了符合DISH定义(转氨酶>正常参考值上限10倍)以及随后发生ALF的DISH患者。采用单因素回归分析确定与预后相关的因素。结合约登指数及受试者工作特征(ROC)分析来确定预测ALF及住院死亡的预后评分的最佳截断值。使用配对数据非参数ROC曲线估计比较ROC曲线下面积(AUROC)值。
193例DISH患者中,20例发生ALF(0.79%),死亡率为60.0%。国际标准化比值、胆红素、白蛋白和肌酐是与ALF及死亡相关的独立预测因素。预后评分表现出色:终末期肝病模型(MELD)评分≥15预测ALF(AUROC 0.917,敏感性90.0%,特异性88.4%),≥18预测死亡(AUROC 0.823,敏感性86.9%,特异性89.1%);简易白蛋白 - 胆红素(ALBI)评分≥ - 30预测ALF及死亡(ALF:AUROC 0.835,敏感性80.0%,特异性72.2%;死亡:AUROC 0.808,敏感性76.9%,特异性69.3%);ALBI评分≥ - 2预测ALF及死亡(ALF:AUROC 0.806,敏感性80.0%,特异性77.4%;死亡:AUROC 0.799,敏感性76.9%,特异性74.3%)。血小板 - ALBI评分在预测ALF及死亡方面也表现良好(AUROC分别为0.786和0.699)。MELD和EZ - ALBI评分在预测ALF(Z = 1.688,P = 0.091)及死亡(Z = 0.322,P = 0.747)方面表现相似。
MELD评分是DISH患者发生ALF及死亡的最佳预测指标。EZ - ALBI评分是一种更简单但有效的评分,有望成为登革热患者的替代预后工具。